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To the Editor, 
1. INTRODUCTION 
Dietary intervention is effective for the management of eosinophilic oesophagitis (EoE) in 
both adults and children [1]. The majority of research has been conducted in Spain or the 
United States [1], with no studies of dietary intervention published in the United 
Kingdom. Restrictive elimination diets can be challenging and swallowed topical 
corticosteroids have also been shown to be an effective treatment in adults [2]. Despite 
their efficacy, disadvantages include risk of candidiasis [3], potential long-term effects 
such as adrenal suppression [3] and off-label medication use. Proton pump inhibitors 
(PPIs) are effective for a proportion of patients [4] although with both PPIs and 
corticosteroids, the underlying triggers of this presumed antigen-mediated condition are 
not identified and continued use is required to maintain efficacy [3]. A key aspect in the 
management of any allergic disease is avoidance of relevant allergens.  
Through a multi-disciplinary collaboration between Adult Allergy, Gastroenterology and 
Dietetics, we launched a service to provide dietary intervention for adults with EoE in a 
UK tertiary referral centre. We recently undertook a retrospective evaluation with the 
aim to describe the clinical phenotype of EoE in our service and to determine the clinico-
pathological response to dietary or medical interventions in this cohort (GSTT service 
evaluation 6195).   
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2. METHODS 
A search of the histology reporting system was performed in patients who had 
oesophageal biopsies taken over two years using the term "eosinophil". Patients were 
also identified by reviewing clinical records. The resulting list was manually screened for 
eligible patients, namely adults (>16 years) with an oesophageal eosinophil count over 15 
per high power field (hpf) and documented history of suggestive symptoms.  
In our pathway (Figure 1), all patients with oesophageal eosinophilia were advised to start 
a PPI as per previous guidelines [5]. Both responsive and non-responsive patients were 
offered a choice between dietary management, corticosteroids or long-term PPI if 
responsive. Prior to dietary intervention patients were assessed by both an Allergist and 
specialist allergy dietitian. They underwent extensive allergy testing using skin prick and 
serum specific IgE tests and were placed on a test directed exclusion diet if any results 
were positive (unless solely sensitised to tree nuts).  If no target foods were identified 
through testing, patients were recommended to undergo the six-food elimination diet 
(SFED), followed by sequential food reintroduction to identify triggers. A further biopsy 
was taken after six weeks of intervention. If the SFED was not successful, steroids or an 
elemental diet were recommended.  
Eosinophil counts and histological response were compared in those who had both pre 
and post-treatment endoscopies for PPIs, steroids, and dietary interventions. All were 
undertaken for a minimum of six weeks for diet and eight weeks for PPI and 
corticosteroids. Complete histological response was defined as an eosinophil count of less 
than 5 cells per hpf, with partial response either a count less than 15 per hpf or a 
reduction of at least 50%. Clinical response was defined as partial (reported improvement 
but not resolution of symptoms) or complete (asymptomatic). Statistical analysis was 
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performed using IBM SPSS Statistics Version 23 (2015). Changes in peak eosinophil counts 
after each treatment were assessed using Wilcoxon signed rank and histological response 
rates using Fisher exact tests with statistical significance set at p < 0.05.  
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3. RESULTS 
We identified 100 patients with a male (n=76/100 [76%]) and Caucasian predominance 
(n=69/73 [95%]), as shown in Table 1. High levels of sensitisation to both food and 
aeroallergens were also seen (Table 1). The most common positive foods on allergy 
testing were: almond (28/57 [49%]), sesame (10/22 [45%]), hazelnut (24/56 [43%]), barley 
(24/58 [41%]),  rye (16/41 [39%]),  cow’s milk (22/60 [37%]), wheat (23/60 [38%]), and 
peanut (18/55 [33%]). Test directed elimination diets included exclusion of cow's milk 
2/10 (20%); cow's milk and gluten 3/10 (30%); cow's milk, fish and tree nuts 2/10 (20%); 
cow's milk, soy and tree nuts 1/10 (10%); gluten, oats, soya and foods containing lipid 
transfer proteins (LTPs) 1/10 (10%); and raw fruits and vegetables 1/10 (10%).  
The majority (n=17/23, 74%) in the PPI group were prescribed 40mg omeprazole. Others 
were prescribed: 20mg omeprazole 1/23 (4%), 30mg lansoprazole 2/23 (9%), 40mg 
pantoprazole 1/23 (4%), unknown PPI 2/23 (9%). In the steroid group 11/12 (92%) were 
prescribed fluticasone via metered dose inhaler (250mcg, n=1; 500mcg, n=5; 750mcg, 
n=2; 1000mcg, n=1; 2000mcg, n=1; unknown dose, n=1) and 1/12 (8%) was prescribed 
oral viscous budesonide (2mg). This was given using an inhalation suspension mixed with 
amino acid formula. 
Outcomes from different interventions are shown in Figure 2. There were no significant 
differences between groups in terms of age, gender, atopy, disease duration or clinical 
features. There was a non-significant trend towards increased response in dietary versus 
pharmacological management. The decrease in median [IQR] peak eosinophil count was 
significant for allergy test-directed (62[38] vs 23 [29]; n=10; P=0.036) and SFED (47[46] vs 
10 [46]; n= 20; P=0.006), but not for any other intervention. Histological response 
(complete or partial) was seen in 35% for PPI (n=23), 50% corticosteroids (n=12), 65% 
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SFED (n=20), and 50% allergy- test directed diets (n=10). Elemental diet induced remission 
for both patients who underwent this intervention. Success was lower (17%) for ‘other 
elimination diets’ (n=6), which most commonly included empirical elimination of dairy 
and wheat. For all treatments, clinical response rates were higher than histological rates, 
particularly for dietary interventions: 52% PPI, 58% steroids, 75% SFED, 90% test-directed, 
83% other elimination diets, and 100% elemental.  
In 14 patients dietary triggers were identified following food reintroduction and these 
were confirmed by either repeat biopsies (n=12) and/or a clear cut return of symptoms 
(n=3). Ten patients completed the reintroduction process, and 5/10 (50%) had a single 
confirmed trigger, 3/10 (30%) two confirmed triggers, 2/10 (20%) three or more 
confirmed triggers. Dairy was the most common trigger (8/14 [57%]), following by gluten 
containing cereals (4/14 [29%]), egg (2/14 [14%]) and (1/14 [7%]) for each of the 
following: soy, nuts, crustaceans and raw fruit. 
Weight loss was common in patients undergoing dietary intervention, with 15/23 (65%) 
experiencing some degree of weight loss and for 4/23 (17%) this was clinically significant 
(>10%). The median pre-diet BMI was 22.8 kg.m-2 (interquartile range 5.0 kg.m-2) and 
14/37 (38%) were overweight (BMI> 25 kg.m-2).  
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4. DISCUSSION 
This retrospective study is the first to describe and report outcomes for dietary and 
medical management of adult EoE in a real life UK clinical setting. Our cohort had similar 
characteristics previously described with a high proportion of males, Caucasians and high 
incidence of atopy. We found a non-significant trend towards better outcomes in dietary 
compared to medical interventions. Response rates for dietary management mirror the 
results of previous studies [1]. Lower response rate to steroids may be due to the small 
sample size or due to inadequate dosages, as well as potential poor adherence.  We 
found lower response rates to PPIs compared to other studies [4], which may also be due 
to poor adherence or inadequate dosing, as only 74% were known to be prescribed the 
recommended amount.  Of note, only half of our overall cohort had a follow up 
endoscopy on treatment and therefore results may be biased if patients responded 
symptomatically to a PPI or steroids and elected not to undergo a further endoscopy. An 
allergy-test directed approach has previously been found to be less effective than other 
dietary approaches, although we saw a higher success rate compared to other adult 
studies [1]. This may be due to the small sample size or use of fresh foods for skin prick 
testing, which warrants further investigation. However, even with a lower chance of 
remission a potential advantage of an allergy-test directed diet over other interventions is 
a less restrictive diet if successful, as in our cohort the majority (8/10) were avoiding 
three foods or less. A four-food elimination diet is another possible approach, although 
there is a lesser established base of evidence compared to other interventions.  
A recent large multicentre trial in Spain found that a “step-up” approach from two food 
elimination (milk and wheat) to four (adding egg and legumes) then six (adding fish and 
tree nuts) overall saved time and reduced endoscopies [6].  Given that our cohort had 
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similar incidences of common food triggers, this may also be an effective approach in our 
population.  
Our higher rates of clinical compared to histological response may be explained in part by 
missing data and lack of a validated tool to measure symptom response, instead relying 
on subjective reporting. It has been shown that symptoms often do not correlate with 
oesophageal biopsy results [7] and recent European guidelines recommend histology as 
the mainstay for diagnosis and monitoring [3]. Repeated endoscopies do place an 
additional burden on both the patient and the health service, but reliance on symptom 
improvement may mask persistent eosinophilia, which in the long-term may lead to 
oesophageal remodelling and stricture formation [8]. It appears that over time EoE in 
adults progresses from an inflammatory to a fibro-stenotic condition [4], this being 
potentially harder to treat.  
An important question remains regarding long-term efficacy of elimination diets for EoE. 
One recent study found that in patients who were able to adhere, dietary elimination 
remained effective, but over half of patients relapsed due to compliance or iatrogenic 
food reintroduction [9]. As more patients are being treated with dietary intervention, 
further evidence regarding long-term outcomes is awaited.  
Although weight loss was common, many patients were overweight and therefore for 
some weight loss may have been intentional or desirable. Nevertheless, the restrictive 
nature of dietary intervention and impact on nutritional status highlights the importance 
of support from a dietitian. The recent AAAAI Workgroup report recommends when to 
refer and offers online resources to support those who may not have access to a dietitian 
[10].  
 9 
Limitations include the retrospective design and small sample size in different treatment 
arms, which likely accounts at least in part for the lack of significant differences between 
groups. Samples undergoing different interventions were not randomised or matched 
which introduces a source of potential bias. Additionally there were missing data, in 
particular half of the cohort did not have a follow-up endoscopy on treatment.  
In conclusion, we have shown that dietary management of adult EoE can be effective in a 
real life UK setting using a multi-disciplinary approach including a specialist dietitian. Less-
restrictive initial approaches such as test-directed or step-up protocols may be preferable, 
even if efficacy is lower. Further research would be beneficial to determine how to 
predict response to treatment as well as focussing on long-term outcomes.   
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Legends to figures 
Figure 1 
Sequence of treatment strategies following diagnosis of EoE. Following a PPI trial, patients 
were offered a choice between diet or corticosteroids. Dashed lines indicate subsequent 
treatment following non-response. *PPI-responsive patients were also offered treatment 
with diet or corticosteroids. 
 
Figure 2 
Histological and clinical response rates to different treatments. Complete histological 
response is defined as eosinophil count < 5 cells/hpf and partial either 5-15/hpf or >50% 
reduction in eosinophil count. A complete clinical response was absence of symptoms 
whereas a partial clinical response was improvement but not resolution of symptoms. 
PPI: proton pump inhibitor, SFED: six food elimination diet, TDED: test directed 
elimination diet, OED: other elimination diet, ED: elemental diet  
 
 Complete response  Partial response  No response  No information 
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Table 1: Patient characteristics 
 
Demographics  (n=100) 
Age (median [IQR]) 35 [11]  
Male (n/N (%)) 76/100  (76) 
Ethnicity (n/N (%))   
Caucasian 69/73  (95) 
Black/ mixed black  4/73  (5) 
Atopic conditions (n/N (%))   
Any 65/87 (75) 
Rhinitis 47/87 (54) 
Asthma 33/87 (38) 
Eczema 17/87 (20) 
Food allergy 24/87 (28) 
Positive allergy tests (n/N (%)) 
Any food or aeroallergen 52/63  (83) 
Aeroallergen 36/52  (69) 
Food  46/62 (74) 
Food- SPT only  38/59 (64) 
Food- IgE only 35/60  (58) 
Symptoms at baseline (n/N (%)) 
Dysphagia 83/91 (91) 
Self-limiting food retention 68/85 (80) 
Food impaction 38/79 (48) 
Heartburn or reflux 42/88 (48) 
Regurgitation or vomiting 31/87 (36) 
Chest pain 15/85 (18) 
Endoscopic features at diagnosis (n/N (%)) 
Trachealisation 50/94 (53) 
Furrows 38/94 (40) 
Stricture 20/94 (21) 
Exudates 16/94 (17) 
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